Armando L Negri

Summary

Country: Argentina

Publications

  1. ncbi Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents
    Armando Luis Negri
    Physiology and Biophysics Department, University of Salvador, Buenos Aires, Argentina
    J Nephrol 17:496-503. 2004
  2. ncbi Calcitriol resistance in hemodialysis patients with secondary hyperparathyroidism
    Armando L Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador School of Medicine, Libertad 836 1 piso, 1012, Buenos Aires, Argentina
    Int Urol Nephrol 46:1145-51. 2014
  3. doi Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease
    Armando Luis Negri
    Facultad de Medicina, Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, 1012, Buenos Aires, Argentina
    Int Urol Nephrol 46:9-17. 2014
  4. doi Evaluation of bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) in hemodialysis patients
    A L Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, Buenos Aires 1012, Argentina
    Osteoporos Int 23:2543-50. 2012
  5. ncbi [Relationship between renal function and bone mineral density in postmenopausal women that undergo bone mass evaluation]
    A L Negri
    Instituto de Investigaciones Metabólicas, Facultad de Medicina, Universidad del Salvador, Buenos Aires, Argentina
    Nefrologia 26:206-11. 2006
  6. ncbi Evaluation of cortical bone by peripheral quantitative computed tomography in continuous ambulatory peritoneal dialysis patients
    Armando Luis Negri
    Instituto de Investigaciones Metabólicas, Beunos Aires, Argentina
    Hemodial Int 10:351-5. 2006
  7. ncbi Proximal tubule endocytic apparatus as the specific renal uptake mechanism for vitamin D-binding protein/25-(OH)D3 complex
    Armando Luis Negri
    Physiology and Biophysics Department, Universidad del Salvador School of Medicine, Buenos Aires, Argentina
    Nephrology (Carlton) 11:510-5. 2006
  8. ncbi Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers
    Armando Luis Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, Buenos Aires 1012, Argentina
    Urol Res 35:247-51. 2007
  9. doi Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers
    Armando Luis Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, Buenos Aires, 1012, Argentina
    Urol Res 36:303-7. 2008
  10. ncbi Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?
    Armando L Negri
    Metabolic Research Institute, Universidad del Salvador, Buenos Aires, Argentina
    J Nephrol 23:653-7. 2010

Collaborators

Detail Information

Publications28

  1. ncbi Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents
    Armando Luis Negri
    Physiology and Biophysics Department, University of Salvador, Buenos Aires, Argentina
    J Nephrol 17:496-503. 2004
    ....
  2. ncbi Calcitriol resistance in hemodialysis patients with secondary hyperparathyroidism
    Armando L Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador School of Medicine, Libertad 836 1 piso, 1012, Buenos Aires, Argentina
    Int Urol Nephrol 46:1145-51. 2014
    ....
  3. doi Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease
    Armando Luis Negri
    Facultad de Medicina, Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, 1012, Buenos Aires, Argentina
    Int Urol Nephrol 46:9-17. 2014
    ..Interventional studies are required in order to clarify the relation of causality between FGF-23 and cardiovascular mortality in this population...
  4. doi Evaluation of bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) in hemodialysis patients
    A L Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, Buenos Aires 1012, Argentina
    Osteoporos Int 23:2543-50. 2012
    ..Hemodialysis patients have a marked decreased in cortical density, thickness, and area with significant reduction in trabecular parameters that correlated with the severity of secondary hyperparathyroidism only in women...
  5. ncbi [Relationship between renal function and bone mineral density in postmenopausal women that undergo bone mass evaluation]
    A L Negri
    Instituto de Investigaciones Metabólicas, Facultad de Medicina, Universidad del Salvador, Buenos Aires, Argentina
    Nefrologia 26:206-11. 2006
    ....
  6. ncbi Evaluation of cortical bone by peripheral quantitative computed tomography in continuous ambulatory peritoneal dialysis patients
    Armando Luis Negri
    Instituto de Investigaciones Metabólicas, Beunos Aires, Argentina
    Hemodial Int 10:351-5. 2006
    ..These findings suggest that pQCT may be a new tool in the assessment of bone fragility in dialysis patients...
  7. ncbi Proximal tubule endocytic apparatus as the specific renal uptake mechanism for vitamin D-binding protein/25-(OH)D3 complex
    Armando Luis Negri
    Physiology and Biophysics Department, Universidad del Salvador School of Medicine, Buenos Aires, Argentina
    Nephrology (Carlton) 11:510-5. 2006
    ....
  8. ncbi Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers
    Armando Luis Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, Buenos Aires 1012, Argentina
    Urol Res 35:247-51. 2007
    ..Patients with pure CaOx stones were younger; they had a low proportion of obese subjects, a higher urinary calcium excretion, and a higher AP index for CaOx...
  9. doi Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers
    Armando Luis Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, Buenos Aires, 1012, Argentina
    Urol Res 36:303-7. 2008
    ..There was either no change or increase in magnesium and citrate, inhibitors of crystallization, and a significant decrease in urine pH only in men...
  10. ncbi Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?
    Armando L Negri
    Metabolic Research Institute, Universidad del Salvador, Buenos Aires, Argentina
    J Nephrol 23:653-7. 2010
    ....
  11. ncbi The klotho gene: a gene predominantly expressed in the kidney is a fundamental regulator of aging and calcium/phosphorus metabolism
    Armando L Negri
    Physiology and Biophysics Department, University of Salvador, Buenos Aires, Argentina
    J Nephrol 18:654-8. 2005
    ..The down-regulation of the renal klotho gene could increase renal damage induced by angiotensin II, while klotho gene induction could have therapeutic possibilities in treating angiotensin II-induced kidney damage...
  12. ncbi Vascular calcifications in chronic kidney disease: are there new treatments?
    Armando Luis Negri
    Physiology and Biophysics Department, Universidad del Salvador, Buenos Aires, Argentina
    Curr Vasc Pharmacol 3:181-4. 2005
    ..A better understanding of the processes of VC is leading to therapies to retard or improve this phenomenon and will probably have an important impact on patient mortality...
  13. ncbi Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis
    Armando Luis Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, Buenos Aires 10 12, Argentina
    Urol Res 31:378-81. 2003
    ..We conclude that renal phosphate leak is an infrequent finding in patients with idiopathic hypercalciuria and is not associated with a higher urinary calcium loss...
  14. ncbi Lean mass estimation by creatinine kinetics and dual-energy x-ray absorptiometry in peritoneal dialysis
    Armando L Negri
    Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina
    Nephron Clin Pract 95:c9-14. 2003
    ..Malnutrition is widely prevalent in dialysis. Malnourished patients present depletion of somatic protein stores and a decrease in lean body mass (LBM) that can be measured by different techniques...
  15. ncbi Serum crosslaps as bone resorption marker in peritoneal dialysis
    Armando Luis Negri
    Instituto de Investigaciones Metabólicas, Fresenius Medical Care Branch Caballito, Buenos Aires, Argentina
    Perit Dial Int 22:628-30. 2002
  16. ncbi Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis
    Armando L Negri
    Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina
    Perit Dial Int 24:163-8. 2004
    ..The usefulness of bone mass measurements and bone turnover markers to estimate the risk of fracture and the type of underlying renal osteodystrophy are not well established in patients on peritoneal dialysis (PD)...
  17. ncbi Bone densitometry in a patient with hypophosphatemic osteomalacia
    Armando L Negri
    Instituto de Investigaciones Metabólicas, Libertad 836, 1 piso, 1012, Buenos Aires, Argentina
    J Bone Miner Metab 22:514-7. 2004
    ..This case shows the importance of bone densitometry in the follow-up of patients with suspected osteomalacia...
  18. ncbi [Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family]
    Armando Luis Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina
    Medicina (B Aires) 64:103-6. 2004
    ..Genomic DNA analysis performed in patient No 3, showed missense mutation with substitution of arginine at position 179 for glutamine. The family was catalogued as having autosomal dominant hypophosphatemic rickets/osteomalacia...
  19. doi Metabolic risk factors in children with kidney stone disease
    Francisco R Spivacow
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina
    Pediatr Nephrol 23:1129-33. 2008
    ..Very often there is a positive family history of renal stone disease in first- and second-degree relatives...
  20. ncbi [Citrate and renal stones]
    Elisa E del Valle
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina
    Medicina (B Aires) 73:363-8. 2013
    ....
  21. ncbi Clinical and metabolic risk factor evaluation in young adults with kidney stones
    Francisco R Spivacow
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Libertad 836 1 piso, Buenos Aires 1012, Argentina
    Int Urol Nephrol 42:471-5. 2010
    ..If there is really a change of metabolic abnormalities with age it would be interesting to study risk factors in the intermediate population: young adults...
  22. ncbi [Diet in the treatment of renal lithiasis. Pathophysiological basis]
    Armando L Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina
    Medicina (B Aires) 73:267-71. 2013
    ..In conclusion, diet is a key element in the management of the patient with kidney stones but always subordinated to present metabolic risk factors...
  23. ncbi Prevalence of urolithiasis in the autonomous city of Buenos Aires, Argentina
    Irene Pinduli
    Board of Urolithiasis, Buenos Aires Nephrology Association, Buenos Aires, Argentina
    Urol Res 34:8-11. 2006
    ..Prevalence of urolithiasis increases with age both in men and in women...
  24. doi Long-term treatment of renal lithiasis with potassium citrate
    Francisco R Spivacow
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina
    Urology 76:1346-9. 2010
    ....
  25. ncbi Hypomagnesaemia/hypokalemia associated with the use of esomeprazole
    Armando L Negri
    Instituto de Investigaciones Metabólicas, Universidad del Salvador, School of Medicine, Buenos Aires, Argentina
    Curr Drug Saf 6:204-6. 2011
    ..In this light we discuss the possible etiology of proton pump inhibitor related hypomagnesaemia/hypokalemia...
  26. ncbi [Calcimimetic agents in the treatment of hyperparathyroidism secondary to chronic renal failure]
    Armando L Negri
    Instituto de Investigaciones Metabólicas, Facultad de Medicina Universidad del Salvador, Buenos Aires, Argentina
    Medicina (B Aires) 63:165-71. 2003
    ..Thus calcimimetic compounds have considerable potential as new drugs for the treatment of secondary hyperparathyroidism and uremic bone disease...
  27. ncbi Hereditary hypophosphatemias: new genes in the bone-kidney axis
    Armando L Negri
    Metabolic Research Institute, University of Salvador School of Medicine, Buenos Aires, Argentina
    Nephrology (Carlton) 12:317-20. 2007
    ..This provides a mechanism for the skeleton to communicate with the kidney to coordinate the mineralization of extracelular matrix and the renal handling of phosphate...
  28. ncbi Biomechanical impact of aluminum accumulation on the pre- and post-yield behavior of rat cortical bone
    Gustavo Roberto Cointry
    Center for P Ca Metabolism Studies CEMFoC, Faculty of Medicine, National University of Rosario, Argentina
    J Bone Miner Metab 23:15-23. 2005
    ....